These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19519833)

  • 1. Elevated aldosterone levels in patients with androgenetic alopecia.
    Arias-Santiago S; Gutiérrez-Salmerón MT; Castellote-Caballero L; Naranjo-Sintes R
    Br J Dermatol; 2009 Nov; 161(5):1196-8. PubMed ID: 19519833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and aldosterone levels in women with early-onset androgenetic alopecia.
    Arias-Santiago S; Gutiérrez-Salmerón MT; Buendía-Eisman A; Girón-Prieto MS; Naranjo-Sintes R
    Br J Dermatol; 2010 Apr; 162(4):786-9. PubMed ID: 19906217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study.
    Arias-Santiago S; Gutiérrez-Salmerón MT; Castellote-Caballero L; Buendía-Eisman A; Naranjo-Sintes R
    J Am Acad Dermatol; 2010 Sep; 63(3):420-9. PubMed ID: 20619491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is androgenetic alopecia a risk for atherosclerosis?
    Dogramaci AC; Balci DD; Balci A; Karazincir S; Savas N; Topaloglu C; Yalcin F
    J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):673-7. PubMed ID: 19250324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
    Arias-Santiago S; Arrabal-Polo MA; Buendía-Eisman A; Arrabal-Martín M; Gutiérrez-Salmerón MT; Girón-Prieto MS; Jimenez-Pacheco A; Calonje JE; Naranjo-Sintes R; Zuluaga-Gomez A; Serrano Ortega S
    J Am Acad Dermatol; 2012 Mar; 66(3):401-8. PubMed ID: 21835498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with a large prostate show a higher prevalence of androgenetic alopecia.
    Chen W; Yang CC; Chen GY; Wu MC; Sheu HM; Tzai TS
    Arch Dermatol Res; 2004 Nov; 296(6):245-9. PubMed ID: 15517324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgenetic alopecia and insulin resistance in young men.
    González-González JG; Mancillas-Adame LG; Fernández-Reyes M; Gómez-Flores M; Lavalle-González FJ; Ocampo-Candiani J; Villarreal-Pérez JZ
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):494-9. PubMed ID: 19094069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone excess and resistance to 24-h blood pressure control.
    Pimenta E; Gaddam KK; Pratt-Ubunama MN; Nishizaka MK; Cofield SS; Oparil S; Calhoun DA
    J Hypertens; 2007 Oct; 25(10):2131-7. PubMed ID: 17885558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trace elements content and hormonal profiles in women with androgenetic alopecia.
    Skalnaya MG; Tkachev VP
    J Trace Elem Med Biol; 2011 Jan; 25 Suppl 1():S50-3. PubMed ID: 21167696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of androgenetic alopecia and hypertension.
    Ahouansou S; Le Toumelin P; Crickx B; Descamps V
    Eur J Dermatol; 2007; 17(3):220-2. PubMed ID: 17478384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
    Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
    Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgenetic alopecia: does its presence change our perceptions?
    Karaman GC; Dereboy C; Dereboy F; Carman E
    Int J Dermatol; 2006 May; 45(5):565-8. PubMed ID: 16700793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of coronary heart disease in men with androgenetic alopecia.
    Sasmaz S; Senol M; Ozcan A; Dogan G; Tuncer C; Akyol O; Sener S
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):123-5. PubMed ID: 10343940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of insulin resistance and comparison of various insulin sensivity indices in women with androgenetic alopecia.
    Ekmekci TR; Ucak S; Basat O; Koslu A; Altuntas Y
    Eur J Dermatol; 2007; 17(1):21-5. PubMed ID: 17324822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism.
    Pang TC; Bambach C; Monaghan JC; Sidhu SB; Bune A; Delbridge LW; Sywak MS
    ANZ J Surg; 2007 Sep; 77(9):768-73. PubMed ID: 17685956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association between blood pressure and circulating hormonal factors with left ventricular mass in patients with essential hypertension older than 55 years of age].
    González Quijada S; Luque Otero M; Fernández-Cruz A; Almería C; Bagazgoitia Barrera J; Moya Marín FJ
    Med Clin (Barc); 1997 Oct; 109(12):441-4. PubMed ID: 9441177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
    Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
    Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of insulin in hypertension with high and low levels of renin].
    Sindelka G; Widimský J; Prázný M; Kasalová Z; Skrha J
    Cas Lek Cesk; 2001 Apr; 140(7):205-8. PubMed ID: 11374224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.